Sinoway Industrial Co., Ltd.

Granisetron Hcl 107007-88-9 Granisetron Hcl 107007-88-9

Granisetron Hcl 107007-88-9
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

1.Basic information of Granisetron Hcl 107007-88-9:

Product name

Granisetron Hcl / Granisetronhydrochloride

CAS No.

107007-88-9

M.F.

C18H25CIN40

Appearance

White powder

Assay

97.0% - 102%

Ph

4.0 - 6.5

Standard

EP / BP / USP

Certificate

GMP / DMF


2.Usage of Granisetron Hcl 107007-88-9 :


Granisetron hydrochloride is a highly selective serotonin 3 (5-HT3) receptor antagonist with good preventive and therapeutic effects on nausea and vomiting caused by radiotherapy, chemotherapy and surgery. Radiotherapy, chemotherapy and surgery can cause 5-HT release from intestinal chromaffin cells. 5-HT activates the 5-HT3 receptor in the central or vagal nerve terminals and causes vomiting reflex. The mechanism of this product to control nausea and vomiting is to inhibit the occurrence of nausea and vomiting by antagonizing the 5-HT3 receptor in the central chemosensory region and peripheral vagal nerve endings. This product has high selectivity and no adverse reactions such as extrapyramidal reaction and excessive sedation. Common side effects are headache, burnout, fever, constipation and gastrointestinal dysfunction, and occasionally transient asymptomatic liver transaminase increases. The above reaction is mild and requires no special treatment.

3.COA of Granisetron Hcl 107007-88-9 :

COA of Granisetron Hcl 107007-88-9


  • Sugammadex Sodium 343306-79-6
    Basic information of Sugammadex sodium:NameSugammadex sodiumAliasORG-25969/SugaMMadex; Sugammadex Na; Sugammadex IMP; Sugammadex soidum 343306-79-6; Sugammadex sodium iMpurity; 6A,6B,6C,6D,6E,6F,6G,6H... Sugammadex Sodium 343306-79-6
  • Lenvatinib 857890-39-2
    Basic information of LenvatinibNameLenvatinibAliasLenvatinib MesylateCAS NO.857890-39-2Molecular FormulaC21H19ClN4O4.CH4O3SQuality Standard EPGrade StandardMedicine grade / 99% minPackage Size25kg/dr... Lenvatinib 857890-39-2
  • Azilsartan 147403-03-0
    Basic information of AzilsartanNameAzilsartan Alias2-Ethoxy-1-[[2'-(4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid; Tak 536; Unii-F9nux55p23;2-ethoxy-3-((... Azilsartan 147403-03-0
  • Dabigatran Etexilate 211915-06-9
    Basic information of Dabigatran etexilate :NameDabigatran etexilateAliasBIBR-1048(Dabigatran etexilate);N-[2-[4-[N-(Hexyloxycarbonyl)aMidino]phenylaMinoMethyl]-1-Methyl-1H-benziMidazol-5-ylcarbonyl]-... Dabigatran Etexilate 211915-06-9

MORE_DETAIL Granisetron Hcl 107007-88-9

1.Basic information of Granisetron Hcl 107007-88-9:

Product name

Granisetron Hcl / Granisetronhydrochloride

CAS No.

107007-88-9

M.F.

C18H25CIN40

Appearance

White powder

Assay

97.0% - 102%

Ph

4.0 - 6.5

Standard

EP / BP / USP

Certificate

GMP / DMF


2.Usage of Granisetron Hcl 107007-88-9 :


Granisetron hydrochloride is a highly selective serotonin 3 (5-HT3) receptor antagonist with good preventive and therapeutic effects on nausea and vomiting caused by radiotherapy, chemotherapy and surgery. Radiotherapy, chemotherapy and surgery can cause 5-HT release from intestinal chromaffin cells. 5-HT activates the 5-HT3 receptor in the central or vagal nerve terminals and causes vomiting reflex. The mechanism of this product to control nausea and vomiting is to inhibit the occurrence of nausea and vomiting by antagonizing the 5-HT3 receptor in the central chemosensory region and peripheral vagal nerve endings. This product has high selectivity and no adverse reactions such as extrapyramidal reaction and excessive sedation. Common side effects are headache, burnout, fever, constipation and gastrointestinal dysfunction, and occasionally transient asymptomatic liver transaminase increases. The above reaction is mild and requires no special treatment.

3.COA of Granisetron Hcl 107007-88-9 :

COA of Granisetron Hcl 107007-88-9

Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China